See the DrugPatentWatch profile for propylthiouracil
What does propylthiouracil (PTU) do in the body?
Propylthiouracil (PTU) is an antithyroid medicine used to treat hyperthyroidism (an overactive thyroid). It works by lowering thyroid hormone production and by slowing conversion of T4 to the more active T3 (both actions reduce circulating thyroid hormone levels).
What are the main mechanisms (MOA) of PTU?
PTU’s mechanism of action is usually described in two connected steps:
- It inhibits thyroid hormone synthesis by blocking thyroid peroxidase (which is needed to make thyroid hormones from iodide).
- It decreases the peripheral conversion of T4 to T3 (which reduces the amount of active T3 available to tissues).
What is PTU used for, and how does its MOA translate to treatment effects?
Because PTU reduces thyroid hormone levels, it helps control symptoms of hyperthyroidism such as fast heart rate, tremor, weight loss, and heat intolerance. Clinical improvement typically follows as hormone levels fall and the body’s hormone effects diminish.
How does PTU compare with methimazole (and why does MOA matter clinically)?
Both PTU and methimazole are antithyroid drugs that reduce thyroid hormone production, but PTU also reduces T4-to-T3 conversion. That extra step is one reason PTU is sometimes chosen in specific clinical situations.
Key safety angle tied to its MOA
By suppressing thyroid function, PTU can lead to hypothyroidism if doses are too high, and to liver toxicity (a known risk with PTU). Monitoring is used to balance symptom control with avoiding low thyroid hormone levels.
Sources
I don’t have the provided reference material needed to cite the exact MOA statements you want. If you share your course note, textbook excerpt, or a link/source you’re using, I can rewrite the MOA exactly to match it (and add precise citations).